Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Pcv13

Research Leaders

17 sponsors active, led by Merck Sharp & Dohme LLC

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Unknown4
Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05535868Not ApplicableCompletedPrimary

Experimental Human Pneumococcal Challenge With SPN3

NCT06638333CompletedPrimary

Prevalence and Serotype Distribution of Streptococcus Pneumoniae in Healthy Vietnamese Children From 6 Months to 5 Years Old

NCT05429541UnknownPrimary

Pneumococcal Carriage and Serotype Distribution in Children With Otitis Media in Malaysia.

NCT04974294Phase 4UnknownPrimary

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)

NCT05140720Not ApplicableUnknownPrimary

Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age

NCT04594785UnknownPrimary

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

NCT00471757CompletedPrimary

Etiology of Community Acquired Pneumonia

NCT00808821Completed

Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees

Showing all 8 trials

Research Network

Common Treatments

  • Pcv131
  • Pneumosil1
  • Saline For Injection1
  • Serotype 3 Experimental Human Pneumococcal Challenge Liverpool Isolate Liv014s31
  • Serotype 3 Experimental Human Pneumococcal Challenge Malawi Isolate Mlw10v1

Active Sponsors

  • Merck Sharp & Dohme LLC2
  • Pfizer2
  • Liverpool School of Tropical Medicine2
  • Tam Anh Research Institute1
  • Medical Corps, Israel Defense Force1

Top Investigators

Related Conditions

  • Haemophilus Influencae1
  • Vaccine Preventable Disease1
  • Group A Streptococcus1
  • Streptococcus Pyogenes Infection1
  • Neisseria Meningitides Meningitis1

Activity Timeline